Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
XFOR | X4 Pharmaceuticals, Inc | WYZGA MICHAEL S | Director | Aug 18, 2023 | Buy | $1.20 | 25,000 | 29,875 | 76,667 | Aug 22, 2023, 04:09 PM | |
EXAS | EXACT SCIENCES CORP | WYZGA MICHAEL S | Director | Feb 26, 2021 | Option Exercise | $26.98 | 10,108 | 272,714 | 21,579 | Mar 02, 2021, 07:00 PM | |
EXAS | EXACT SCIENCES CORP | WYZGA MICHAEL S | Director | Feb 26, 2021 | Sale | $130.11 | 19,021 | 2,474,822 | 2,558 | Mar 02, 2021, 07:00 PM | |
EXAS | EXACT SCIENCES CORP | WYZGA MICHAEL S | Director | Jul 31, 2019 | Sale | $117.93 | 5,000 | 589,650 | 8,913 | Aug 02, 2019, 04:25 PM | |
EXAS | EXACT SCIENCES CORP | WYZGA MICHAEL S | Director | Jul 31, 2019 | Option Exercise | $26.98 | 2,500 | 67,450 | 13,913 | Aug 02, 2019, 04:25 PM | |
EXAS | EXACT SCIENCES CORP | WYZGA MICHAEL S | Director | Feb 28, 2019 | Sale | $96.00 | 500 | 48,000 | 8,612 | Mar 01, 2019, 05:34 PM | |
EXAS | EXACT SCIENCES CORP | WYZGA MICHAEL S | Director | Aug 28, 2018 | Sale | $74.85 | 2,468 | 184,730 | 9,112 | Aug 30, 2018, 05:26 PM | |
EXAS | EXACT SCIENCES CORP | WYZGA MICHAEL S | Director | May 10, 2018 | Sale | $51.53 | 7,402 | 381,447 | 10,974 | May 11, 2018, 04:48 PM | |
AKBA | Akebia Therapeutics, Inc. | WYZGA MICHAEL S | Director | Mar 25, 2014 | Buy | $17.00 | 1,500 | 25,500 | 1,500 | Mar 27, 2014, 04:01 PM | |
GENZ | GENZYME CORP | WYZGA MICHAEL S | Executive VP and CFO | Apr 04, 2011 | Option Exercise | $74.00 | 29,250 | 2,164,500 | 0 | Apr 06, 2011, 11:49 AM | |
GENZ | GENZYME CORP | WYZGA MICHAEL S | Executive VP and CFO | Apr 04, 2011 | Option Exercise | $74.00 | 24,475 | 1,811,150 | 29,250 | Apr 06, 2011, 11:49 AM | |
GENZ | GENZYME CORP | WYZGA MICHAEL S | Executive VP and CFO | Apr 04, 2011 | Option Exercise | $74.00 | 3,630 | 268,620 | 0 | Apr 06, 2011, 11:49 AM |